Track topics on Twitter Track topics that are important to you
Molecular diagnostics firm Progenity Inc. (women's health, reproductive medicine, and oncology testing) raised $125mm in a Series B round of equity and debt led by a fund managed by returning backer A...
Venture capital activity ended the year with a strong finish in San Diego, as investors poured $498.4 million into 61 companies during the last three months of 2017, according to Venture Monitor data ...
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and is caused by an expansion of cytosine-guanine-guanine (CGG) repeats in the FMR1 gene. Female premutation alle...
Progenity is a biotechnology company with a market-leading presence in Womenâs Health molecular testing and a pipeline of proprietary tests and therapeutic applications under...
We have published hundreds of Progenity, Inc. news stories on BioPortfolio along with dozens of Progenity, Inc. Clinical Trials and PubMed Articles about Progenity, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progenity, Inc. Companies in our database. You can also find out about relevant Progenity, Inc. Drugs and Medications on this site too.